Dr. Nancy Graves, M.D

NPI: 1013138361
Total Payments
$11,051
2024 Payments
$1,158
Companies
39
Transactions
667
Medicare Patients
781
Medicare Billing
$142,965

Payment Breakdown by Category

Food & Beverage$10,938 (99.0%)
Education$113.07 (1.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $10,938 662 99.0%
Education $113.07 5 1.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $1,796 136 $0 (2024)
Otsuka America Pharmaceutical, Inc. $1,387 83 $0 (2024)
ITI, Inc. $982.14 46 $0 (2023)
Allergan, Inc. $810.43 62 $0 (2020)
Sunovion Pharmaceuticals Inc. $796.82 53 $0 (2022)
Neurocrine Biosciences, Inc. $606.72 19 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $583.22 40 $0 (2024)
Lundbeck LLC $432.55 26 $0 (2024)
Teva Pharmaceuticals USA, Inc. $399.85 22 $0 (2024)
Ironshore Pharmaceuticals Inc. $310.53 8 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,158 65 ABBVIE INC. ($248.10)
2023 $2,546 159 ABBVIE INC. ($813.33)
2022 $1,640 108 ABBVIE INC. ($500.87)
2021 $1,727 92 ITI, Inc. ($375.44)
2020 $514.68 35 Allergan, Inc. ($131.28)
2019 $1,573 91 Allergan Inc. ($289.93)
2018 $1,135 73 Allergan Inc. ($252.70)
2017 $756.96 44 Otsuka America Pharmaceutical, Inc. ($199.13)

All Payment Transactions

667 individual payment records from CMS Open Payments — Page 1 of 27

Date Company Product Nature Form Amount Type
12/19/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $27.58 General
Category: PSYCHIATRY
12/18/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $23.28 General
Category: Neuropsychiatry
12/18/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $22.43 General
Category: NEUROSCIENCE
12/17/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $5.11 General
Category: PSYCHIATRY
12/16/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $14.54 General
Category: PSYCHIATRY
12/12/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $27.84 General
Category: Psychiatry/Psychology
12/12/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $20.48 General
Category: PSYCHIATRY
12/09/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $19.81 General
Category: PSYCHIATRY
12/06/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $11.67 General
Category: PSYCHIATRY
12/05/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $17.17 General
Category: NEUROSCIENCE
12/04/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $28.39 General
Category: Neuropsychiatry
12/03/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $15.94 General
Category: NEUROSCIENCE
11/26/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $23.60 General
Category: Central Nervous System
11/21/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $14.20 General
Category: PSYCHIATRY
11/21/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $13.85 General
Category: PSYCHIATRY
11/20/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $24.79 General
Category: Psychiatry/Psychology
11/19/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $18.86 General
Category: NEUROSCIENCE
11/15/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $17.02 General
Category: Neuropsychiatry
11/14/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $15.40 General
Category: PSYCHIATRY
11/14/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $11.00 General
Category: PSYCHIATRY
11/13/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage In-kind items and services $22.78 General
Category: SCHIZOPHRENIA
11/13/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $6.83 General
Category: NEUROSCIENCE
11/11/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $25.95 General
Category: PSYCHIATRY
11/07/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $20.24 General
Category: NEUROSCIENCE
10/31/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $14.83 General
Category: CNS

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 1 131 360 $87,760 $28,292
2022 5 209 522 $118,507 $39,194
2021 4 235 525 $114,441 $47,337
2020 4 206 471 $82,136 $28,141
Total Patients
781
Total Services
1,878
Medicare Billing
$142,965
Procedure Codes
14

All Medicare Procedures & Services

14 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 131 360 $87,760 $28,292 32.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 150 421 $102,045 $34,122 33.4%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 19 19 $7,980 $2,827 35.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 15 20 $6,580 $1,947 29.6%
36415 Insertion of needle into vein for collection of blood sample Office 2022 14 51 $1,033 $151.44 14.7%
82746 Folic acid level, serum Office 2022 11 11 $869.00 $147.85 17.0%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 159 425 $89,830 $37,631 41.9%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 39 51 $13,825 $5,568 40.3%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 26 26 $10,320 $4,070 39.4%
36415 Insertion of needle into vein for collection of blood sample Office 2021 11 23 $465.75 $69.00 14.8%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 147 346 $67,800 $22,550 33.3%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2020 24 88 $6,930 $2,724 39.3%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 21 22 $5,280 $2,006 38.0%
99238 Hospital discharge day management, 30 minutes or less Facility 2020 14 15 $2,126 $861.30 40.5%

About Dr. Nancy Graves, M.D

Dr. Nancy Graves, M.D is a Psychiatry healthcare provider based in Texarkana, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1013138361.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nancy Graves, M.D has received a total of $11,051 in payments from pharmaceutical and medical device companies, with $1,158 received in 2024. These payments were reported across 667 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($10,938).

As a Medicare-enrolled provider, Graves has provided services to 781 Medicare beneficiaries, totaling 1,878 services with total Medicare billing of $142,965. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Location Texarkana, TX
  • Active Since 05/02/2007
  • Last Updated 10/25/2022
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • NPI Number 1013138361

Products in Payments

  • VRAYLAR (Drug) $2,602
  • REXULTI (Drug) $1,419
  • CAPLYTA (Drug) $1,077
  • LATUDA (Drug) $796.82
  • INGREZZA (Drug) $606.72
  • TRINTELLIX (Drug) $511.36
  • ABILIFY MAINTENA (Drug) $315.92
  • AUSTEDO (Drug) $254.68
  • Jornay PM 20mg capsules (Bottle of 100) (Drug) $234.98
  • Dyanavel XR (Drug) $225.12
  • SUNOSI (Drug) $218.81
  • QUDEXY XR Topiramate Extended Release Capsules (Drug) $179.60
  • Auvelity (Drug) $167.47
  • NUEDEXTA (Drug) $142.70
  • INVEGA SUSTENNA (Drug) $134.82
  • WAKIX (Drug) $131.62
  • Evekeo (Drug) $131.15
  • BELSOMRA (Drug) $131.07
  • Sunosi (Drug) $129.19
  • Austedo XR (Drug) $126.88

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Texarkana